Advances in Antibody Engineering for In Vitro Diagnostics and Drug Discovery

Sino Biological is at the cusp of a new era in healthcare innovation, particularly in the field of antibody engineering. The "Advances in Antibody Engineering for In Vitro Diagnostics and Drug Discovery" symposium is designed to bring together the brightest minds in biotechnology to explore groundbreaking advancements in monoclonal antibody engineering and their profound impact on therapeutic development.

Why You Should Attend:

• Cutting-edge Insights: Dive into the latest technological breakthroughs and strategies for creating antibodies with enhanced efficacy and specificity.
• Success Stories: Hear firsthand from industry leaders about the real-world applications of engineered antibodies, especially in oncology and diagnostics.
• Networking: Connect with professionals, academics, and students who are at the forefront of biotechnological innovation.
• Collaborative Opportunities: Engage in discussions that could lead to innovative solutions and advancements in antibody engineering.

Symposium Highlights:

Keynote Presentations by distinguished speakers such as Dr. Anton Shostak from Bayer AG, Dr. Peter Carl from Safia Technologies GmbH, Dr. Tim Ermak from Silica corpora GmbH, and Dr. Jing Gong from Sino Biological Europe GmbH.
Interactive Sessions to discuss current trends, challenges, and opportunities in antibody engineering.
Networking Opportunities with a catered reception for forging valuable connections and collaborations.

REGISTER